Back to search

Article

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

2024-07-02

Abstract excerpt

<h4>ABSTRACT</h4> Leukemic stem cells (LSCs) fuel acute myeloid leukemia (AML) growth and relapse, but therapies tailored towards eradicating LSCs without harming healthy hematopoietic stem cells (HSCs) are lacking. FLT3 is considered an important therapeutic target due to frequent mutation in AML and association with relapse. However, there has been limited clinical success with FLT3 targeting, suggesting either...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1a024566-7d2a-5714-8415-01cd69e3c83d
DOI
10.1101/2024.06.30.601363
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cellsDOI 10.1101/2024.06.30.601363
Select a neighboring publication to make it the new centre.